✦ LIBER ✦

The interference between metformin treatment and TSH level in euthyroid type 2 diabetic patients

✍ Scribed by Soumaya Kouidhi, Rym Berhouma, Meriem Ammar, Kamel Rouissi, Hafawa Abid, Slim Jarboui, Raja Marrakchi, Barbara Demeneix, Hajer Guissouma, Amel Benammar Elgaaied

Book ID: 118778198
Publisher: Springer-Verlag
Year: 2012
Tongue: English
Weight: 207 KB
Volume: 22
Category: Article
ISSN: 1054-2523
DOI: 10.1007/s00044-012-0136-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effect of metformin treatment on VEG

The effect of metformin treatment on VEGF and PAI-1 levels in obese type 2 diabetic patients

✍ Canan Ersoy; Sinem Kiyici; Ferah Budak; Barbaros Oral; Metin Guclu; Cevdet Duran 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Serum sialic acid changes in type 2 diab

Serum sialic acid changes in type 2 diabetic patients on metformin or rosiglitazone treatment

✍ I. U. Rahman; S. A. Malik; M. Bashir; R. U. Khan; M. Idrees 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

The effects of pioglitazone and metformi

The effects of pioglitazone and metformin on plasma visfatin levels in patients with treatment naive type 2 diabetes mellitus

✍ Gokhan Erdem; Teoman Dogru; Ilker Tasci; Ergun Bozoglu; Ozlem Muhsiroglu; Serkan 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 210 KB

Effects of rosiglitazone and metformin t

Effects of rosiglitazone and metformin treatment on apelin, visfatin, and ghrelin levels in patients with type 2 diabetes mellitus

✍ Nikolaos P.E. Kadoglou; Hercules Tsanikidis; Alkistis Kapelouzou; Ioannis Vrabas 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 280 KB

Efficacy and safety of metformin for tre

Efficacy and safety of metformin for treatment of type 2 diabetes in elderly Japanese patients

✍ Hiroyuki Ito; Yasuhiro Ohno; Takaaki Yamauchi; Yumiko Kawabata; Hiroshi Ikegami 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 391 KB

Metformin–pioglitazone and metformin–ros

Metformin–pioglitazone and metformin–rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome

✍ G. Derosa; A. D'Angelo; P. D. Ragonesi; L. Ciccarelli; M. N. Piccinni; F. Pricol 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB